Supraglottic Airway for Resuscitation Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0+
SponsorChildren's Hospital of Philadelphia

About this trial

This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation

Fluent in English

Oversee the care of newborns on a local level (e.g. nurse manager) or a hospital level (e.g. Chief Quality and Safety Officer)

Fluent in English

Disqualifiers

Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation

Fluent in English

Inborn (not transferred to the hospital after birth)

≥34 weeks' gestation at birth, based on best obstetrical estimate

Trial design

Design model

Parallel

Treatments tested in this trial

  • Enhanced Standard of Care ("Enhanced")

    Other intervention

    Enhanced Standard of Care ("Enhanced") will include: Educational Materials and Outreach, Local Champions, Train the Trainer, Local Simulation Training, and SA Starter Packs.

  • Enhanced Standard of Care ("Enhanced-Plus")

    Other intervention

    Enhanced Standard of Care ("Enhanced-Plus") will include: Educational Materials and Outreach, Local Champions, Train the Trainer, Local Simulation Training, SA Starter Packs, and three additional intensive external facilitation components.

Treatment groups

36,503 Participants
are divided into 2 treatment groups
Group A: Enhanced Standard of Care ("Enhanced")Active comparator 1 intervention
Group B: Enhanced Standard of Care Plus Facilitation ("Enhanced-Plus")Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Penetration of early SA rescue

Proportion of eligible patients treated with SA as an early rescue device. Excludes SA after intubation attempt.

Time frame
Up to 2 years

Secondary outcomes

1

Initial adoption of early SA rescue

Quarters required to reach 10% penetration of SA use among eligible patients at hospital level

Time frame
Up to 2 years
2

Sustainment of early SA rescue

Proportion of SA use among eligible patients per quarter examined using linear mixed effects model to quantitatively assess successful sustainment (slope of penetration proportion positive or not significantly different than 0) versus decay (slope of penetration negative) post-implementation.

Time frame
Up to 1 year

Other outcomes

1

Neonatal Intensive Care Unit (NICU) Admission

Proportion of any admission to Neonatal Intensive Care Unit (NICU) before hospital discharge at hospital level, assessed among patients ≥35 weeks' Gestational Age (GA)

Time frame
Up to 30 days of life
2

Hypoxic Ischemic Encephalopathy (HIE)

Proportion of moderate to severe HIE at hospital level, assessed among patients ≥35 weeks' Gestational Age (GA)

Time frame
Up to 30 days of life
3

Any exposure to Endotracheal Tube

Proportion of any exposure to ventilation through Endotracheal Tube (ETT) prior to hospital discharge, including during resuscitation, at hospital level

Time frame
Up to 30 days of life
4

Hospital Mortality

Proportion of death before hospital discharge, at hospital level

Time frame
Up to 6 months of life

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Children's Hospital of Philadelphia

Lead sponsor

Patient-Centered Outcomes Research Institute

Collaborator